Precision Neuroscience has announced a strategic partnership with Medtronic to pair its brain–computer interface (BCI) technology with Medtronic’s Neuroscience portfolio.
The companies said they will co-develop an integrated solution that combines Precision’s Layer 7 cortical interface with the Medtronic StealthStation surgical navigation system.
Layer 7, which has been in development since 2021 by a team including former Neuralink employees, is a minimally invasive BCI that doesn't rely on electrodes that penetrate and potentially damage brain tissue. Precision said it's designing its implant to help severely paralyzed people and, in the near future, advance stroke rehabilitation and refractory depression treatment.
Precision received FDA clearance last year for Layer 7, which it hopes to commercialize soon.
The companies said their partnership brings together Precision’s high-resolution electrode technology and Medtronic’s real-time 3D surgical navigation platform, the StealthStation system, to deliver a system designed to provide real-time functional and structural information during surgical procedures.
“Our work with Medtronic represents an important step toward advancing how the field understands and interacts with the human brain,” said Precision CEO Michael Mager in a statement. “Precision’s minimally invasive approach allows this technology to reach widespread clinical use, opening the door to new insights and breakthroughs. Partnering with Medtronic accelerates that path— Medtronic’s Cranial & Spinal Technologies business provides ubiquitous and trusted platforms in neurosurgery, and integrating our technology into a tool surgeons already rely on represents a step change in how quickly we can bring these capabilities into everyday practice.”
“At Medtronic, we believe the brain is the next frontier in medicine. For more than 30 years, our products and therapies have improved the lives of patients with neurological conditions. Today, we’re learning more about the brain than ever before,” said Brett Wall, President of Medtronic’s Neuroscience Portfolio, in a statement. “By integrating Precision Neuroscience’s advanced brain mapping technology with our trusted cranial and spinal technology, we’re exploring the future of cranial surgery and accelerating the global adoption of adaptive, intelligent therapies. These kinds of partnerships are not about chasing trends—it’s about delivering real, meaningful breakthroughs for patients and setting new standards for neurological care worldwide.”
